Clinical Trial Update: Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial in ischemic heart disease shows that metformin reduces left ventricular mass.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Wuhan General Hospital of Guangzhou Military Command | Conditions: Left Ventriclar Mass | Phase 4 | Status: COMPLETED